Myocardial Strain Is Associated with Adverse Clinical Cardiac Events in Patients Treated with Anthracyclines
- 1 June 2016
- journal article
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 29 (6) , 522-527.e3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast CancerJournal of Clinical Oncology, 2012
- Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trialsBMC Cancer, 2010
- Anthracycline-Induced CardiomyopathyJACC, 2010
- Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac riskAnnals of Oncology, 2009
- Congestive heart failure in patients treated with doxorubicinCancer, 2003
- Early cardiotoxicity of the CHOP regimen in aggressivenon-Hodgkin’s lymphomaAnnals of Oncology, 2003
- Acute promyelocytic leukemia: evolving therapeutic strategiesBlood, 2002
- Underlying Causes and Long-Term Survival in Patients with Initially Unexplained CardiomyopathyNew England Journal of Medicine, 2000
- A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin.Journal of Clinical Oncology, 1984
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979